Literature DB >> 21037327

Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective.

Cheryl A Vinograd, James B Bussel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21037327      PMCID： PMC2966900          DOI： 10.3324/haematol.2010.030148

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  28 in total

1.  Fetomaternal alloimmune thrombocytopenia treated with intragam.

Authors:  B Dawkins; R M Minchinton
Journal:  Med J Aust       Date:  1999-05-03       Impact factor: 7.738

2.  Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.

Authors:  Günther Giers; Folker Wenzel; Markus Stockschläder; Regina Riethmacher; Horst Lorenz; Boris Tutschek
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

Review 3.  Fetal alloimmune thrombocytopenia: consensus and controversy.

Authors:  J B Bussel; D W Skupski; J G MacFarland
Journal:  J Matern Fetal Med       Date:  1996 Sep-Oct

4.  Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin.

Authors:  J B Bussel; R L Berkowitz; L Lynch; M L Lesser; M J Paidas; C L Huang; J G McFarland
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

5.  A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.

Authors:  C M Radder; A Brand; H H Kanhai
Journal:  Am J Obstet Gynecol       Date:  2001-09       Impact factor: 8.661

Review 6.  Antenatal interventions for fetomaternal alloimmune thrombocytopenia.

Authors:  R Rayment; S J Brunskill; S Stanworth; P W Soothill; D J Roberts; M F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

7.  Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus.

Authors:  James B Bussel; Richard L Berkowitz; Crystal Hung; E Anders Kolb; Megan Wissert; Andrea Primiani; Felicia W Tsaur; Janice G Macfarland
Journal:  Am J Obstet Gynecol       Date:  2010-05-21       Impact factor: 8.661

8.  In utero cerebral hemorrhage in alloimmune thrombocytopenia.

Authors:  J H Herman; M I Jumbelic; R J Ancona; T S Kickler
Journal:  Am J Pediatr Hematol Oncol       Date:  1986

9.  Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions.

Authors:  M F Murphy; P Metcalfe; A H Waters; J Ord; H Hambley; K Nicolaides
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

10.  Antenatal treatment of neonatal alloimmune thrombocytopenia.

Authors:  J B Bussel; R L Berkowitz; J G McFarland; L Lynch; U Chitkara
Journal:  N Engl J Med       Date:  1988-11-24       Impact factor: 91.245
View more
  8 in total

1.  Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.

Authors:  Cedric Ghevaert; Nina Herbert; Louise Hawkins; Nicola Grehan; Philip Cookson; Steve F Garner; Abigail Crisp-Hihn; Paul Lloyd-Evans; Amanda Evans; Kottekkattu Balan; Willem H Ouwehand; Kathryn L Armour; Mike R Clark; Lorna M Williamson
Journal:  Blood       Date:  2013-05-08       Impact factor: 22.113

2.  Fetal and neonatal alloimmune thrombocytopenia.

Authors:  J P Espinoza; J Caradeux; Errol R Norwitz; S E Illanes
Journal:  Rev Obstet Gynecol       Date:  2013

3.  Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.

Authors:  Tamam Bakchoul; Andreas Greinacher; Ulrich J Sachs; Annika Krautwurst; Harald Renz; Habi Harb; Gregor Bein; Peter J Newman; Sentot Santoso
Journal:  Blood       Date:  2013-05-03       Impact factor: 22.113

4.  Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies.

Authors:  Zhi-Jian Liu; James B Bussel; Madhavi Lakkaraja; Francisca Ferrer-Marin; Cedric Ghevaert; Henry A Feldman; Janice G McFarland; Chaitanya Chavda; Martha Sola-Visner
Journal:  Blood       Date:  2015-07-24       Impact factor: 22.113

Review 5.  Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Authors:  Heidi Tiller; Anne Husebekk; Maria Therese Ahlen; Tor B Stuge; Bjørn Skogen
Journal:  Int J Womens Health       Date:  2017-04-19

6.  Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia.

Authors:  Brian Vadasz; Pingguo Chen; Issaka Yougbaré; Darko Zdravic; June Li; Conglei Li; Naadiya Carrim; Heyu Ni
Journal:  Genes Dis       Date:  2015-06-01

Review 7.  Neonatal Immune Incompatibilities between Newborn and Mother.

Authors:  Borros Arneth
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

8.  Successful management of neonatal alloimmune thrombocytopenia in the second pregnancy: a case report.

Authors:  Fabiana Mendes Conti; Sergio Hibner; Thiago Henrique Costa; Marcia Regina Dezan; Maria Giselda Aravechia; Ricardo Antonio D Almeida Pereira; Andrea Tiemi Kondo; Élbio Antônio D'Amico; Mariza Mota; José Mauro Kutner
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.